Expert Review of Hematology

Papers
(The H4-Index of Expert Review of Hematology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Evidence-based indications of platelet-rich plasma therapy63
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians37
Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia37
The biology and management of dyskeratosis congenita and related disorders of telomeres36
Pacritinib for the treatment of patients with myelofibrosis and thrombocytopenia33
A review of FDA-approved acute myeloid leukemia therapies beyond ‘7 + 3’33
COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis28
Immune thrombocytopenia25
The spectrum of beta-thalassemia mutations in the 22 Arab countries: a systematic review23
Complement activation and coagulopathy - an ominous duo in COVID1922
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis22
Avapritinib for Systemic Mastocytosis20
Platelets: the point of interconnection among cancer, inflammation and cardiovascular diseases20
The expression of CD30 and its clinico-pathologic significance in peripheral T-cell lymphomas20
Safety of FLT3 inhibitors in patients with acute myeloid leukemia19
Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment18
Key questions in the new hemophilia era: update on concomitant use of FVIII and emicizumab in hemophilia A patients with inhibitors18
Cardiotoxicity of BTK inhibitors: ibrutinib and beyond17
0.12996697425842